102 studies found for:    "Cushing disease" OR "Hypercortisolism" OR "Cushing Syndrome"
Show Display Options
Download search resultsDownload the search results for:
"Cushing disease" OR "Hypercortisolism" OR "Cushing Syndrome" (102 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Recruiting Study of Adrenalectomy Versus Observation for Subclinical Hypercortisolism
Conditions: Hypercortisolism;   Cushing Syndrome
Intervention: Procedure: Adrenalectomy
2 Completed
Has Results
Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome
Conditions: Cushing's Disease;   Cushing's Syndrome
Intervention: Drug: Mifepristone
3 Recruiting Glucocorticoid Receptor Blockade With Mifepristone in Patients With Mild Adrenal Hypercortisolism
Condition: Mild Hypercortisolism
Intervention: Drug: Mifepristone
4 Recruiting Hypercortisolism and Epicardial Adipose Tissue
Condition: Hypercortisolism
Interventions: Biological: Blood samples for measuring adiponectin, leptin and omentin plasma;   Device: MRI at 3 Tesla
5 Recruiting Adrenalectomy Versus Follow-up in Patients With Subclinical Cushings Syndrome
Condition: Adrenal Tumour With Mild Hypercortisolism
Intervention: Procedure: Adrenalectomy
6 Terminated A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia
Condition: Cushing's Syndrome
Intervention: Drug: Cushing's syndrome confirmation
7 Completed
Has Results
An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome
Condition: Cushing's Syndrome
Intervention: Drug: mifepristone
8 Completed
Has Results
A Study of the Efficacy and Safety of CORLUX in the Treatment of Endogenous Cushing's Syndrome
Condition: Cushing's Syndrome
Intervention: Drug: mifepristone
9 Recruiting Long-term Beneficial Metabolic Effects of Adrenalectomy in Subclinical Cushing's Syndrome of Adrenal Incidentaloma
Condition: Cushing Syndrome
Intervention: Procedure: surgery
10 Recruiting New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome
Condition: Cushing Syndrome
Interventions: Drug: Pentetreotide;   Drug: 18-F-fluorodeoxyglucose;   Drug: (18F)-L-3,4-dihydroxyophenylalanine (18F-DOPA)
11 Recruiting Does Serum-DXM Increase Diagnostic Accuracy of the Overnight DXM Suppression Test in the Work-up of Cushing's Syndrome?
Conditions: Cushing's Syndrome;   Adrenal Incidentalomas;   Alcoholism;   Obesity
Intervention:
12 Terminated
Has Results
Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
Condition: Cushing's Syndrome
Intervention: Drug: Mifepristone
13 Completed Long Term Post Operative Follow-Up of Cushing Syndrome
Condition: Cushing Syndrome
Intervention:
14 Completed Jugular Vein Sampling for Hormone Levels for the Diagnosis of Cushing Syndrome
Condition: Cushing's Syndrome
Intervention:
15 Recruiting Insulin Sensitivity and Substrate Metabolism in Patients With Cushing's Syndrome
Conditions: Cushing's Syndrome;   Insulin Resistance
Intervention: Procedure: Surgery
16 Recruiting Evaluation of 68Ga-DOTATATE PET/CT, Octreotide and F-DOPA PET Imaging in Patients With Ectopic Cushing Syndrome
Condition: Cushing Syndrome
Interventions: Drug: F-DOPA PET Scan;   Drug: Mifepristone;   Drug: Ga-DOTATATE;   Drug: Octreoscan;   Other: CT, MRI
17 Withdrawn Mifepristone in Children With Refractory Cushing's Disease
Condition: Cushing's Disease
Intervention: Drug: mifepristone
18 Unknown  Study of Hypercortisolism in Cushing's Syndrome and Stress-Induced Pseudo-Cushing's Syndrome
Condition: Cushing's Syndrome
Intervention:
19 Completed Dose Response Relationship for Single Doses of Corticotropin Releasing Hormone (CRH) in Normal Volunteers and in Patients With Adrenal Insufficiency
Conditions: Adrenal Gland Hyperfunction;   Adrenal Gland Hypofunction;   Cushing's Syndrome;   Healthy
Intervention: Drug: Ovine Corticotropin-Releasing Hormone (oCRH)
20 Completed Extension Study to Assess the Safety and Efficacy of Pasireotide in Patients With Cushing's Disease
Condition: Cushing Disease
Intervention: Drug: Pasireotide

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years